scholarly journals Depression and Fatigue of Breast Cancer Patients Receiving Chemotherapy during the Covid-19

2021 ◽  
Vol 3 (3) ◽  
pp. 297-304
Author(s):  
Dwi Retnaningsih ◽  
Roudhotul Auliyak ◽  
Mariyati Mariyati ◽  
Enggar Nurnaningsih

Depression in breast cancer patients includes mental shock, inability to accept reality, hopelessness, fear of death, and fear of the future. Depression creates long periods of sadness and worry, usually accompanied by feelings of worthlessness. Fatigue is a symptom that often appears in cancer patients undergoing chemotherapy. Associated with the conditions of the COVID-19 pandemic, cancer patients have an increased risk of transmitting COVID-19 because they have decreased endurance. This study aims to determine the relationship between depression and fatigue in breast cancer patients undergoing chemotherapy at Hospital Sultan Agung Semarang Indonesia. The instruments used in this study were questionnaire of the hospitals anxiety and Depression Scale (HADS) and questionnaire of fatigue, 30 female respondents who suffer from breast cancer and have undergone chemotherapy. Rank Spearman data analysis. P value = 0.000 and correlation coefficient value r = 0.671. There is a relationship between depression and fatigue in breast cancer patients undergoing chemotherapy which has an impact on adherence to chemotherapy for breast cancer patients. The higher the level of depression is, the more severe the level of fatigue in cancer patients.

2015 ◽  
Vol 33 (29_suppl) ◽  
pp. 219-219
Author(s):  
Daniel Curtis McFarland ◽  
Megan Johnson Shen ◽  
Kirk Harris ◽  
Amy Tiersten ◽  
John Mandeli ◽  
...  

219 Background: Patient treatment preferences for the management of anxiety and depression influence adherence and treatment outcomes, yet breast cancer patient preferences for provider-specific pharmacologic management of anxiety and depression is unknown. This study examined breast cancer patients’ antidepressant prescriber preferences and their preferences for treatment by a mental health professional. Methods: Breast cancer patients (Stage 0-IV) were asked two questions: 1) “Would you be willing to have your oncologist treat your depression or anxiety with an antidepressant medication if you were to become depressed or anxious at any point during your treatment?”; and 2) “Would you prefer to be treated by a psychiatrist or mental health professional for problems with either anxiety or depression?” Additionally, the Distress Thermometer and Problem List, Hospital Anxiety and Depression Scale, Risky Families Questionnaire, and demographic information were assessed. Results: One hundred twenty-five participants completed the study. 60.4% were willing to accept an antidepressant from an oncologist and 26.3% preferred treatment by a mental health professional. 77.3% who were willing to receive an antidepressant from their oncologist reported either no preference or that treatment by a mental health professional didn’t matter (p = 0.01). Participants taking antidepressants (p = 0.02) or reporting high chronic stress (p = 0.03) preferred a mental health professional. Conclusions: The majority of patients accepted antidepressant prescribing by their oncologist; only a minority preferred treatment by a mental health professional. These findings suggest the benefit for promoting education of oncologists to assess psychological symptoms and manage anxiety and depression as a routine part of an outpatient visit.


1999 ◽  
Vol 29 (6) ◽  
pp. 1335-1345 ◽  
Author(s):  
R. H. OSBORNE ◽  
G. R. ELSWORTH ◽  
D. W. KISSANE ◽  
S. A. BURKE ◽  
J. L. HOPPER

Background. Assessment of adjustment of patients in cancer treatment trials is becoming more common and increasingly regarded as a useful outcome measure. The widely used Mental Adjustment to Cancer (MAC) Scale was designed to measure Fighting Spirit (FS), Anxious Preoccupation (AP), Helpless–hopelessness (HH) and Fatalism.Methods. Questionnaire responses from 632 breast cancer patients were randomly divided into two groups, one for exploratory analyses and possible scale refinement, and the other for validation purposes.Results. Estimates of reliability (Cronbach's α) were satisfactory for two scales, FS (α = 0·85) and HH (α = 0·81), but lower for AP (α = 0·65) and Fatalism (α = 0·64). Exploratory factor analysis suggested that the MAC Scale might be measuring six independent constructs including two related to Fighting Spirit (Positive Orientation to the Illness, Minimizing the Illness), two related to Fatalism (Fatalism-revised, Loss of Control), a construct we have named Angst, and an unchanged HH construct. Scales developed to measure these constructs were satisfactorily replicated in confirmatory analyses but some reliabilities were lower than desirable. The general structure of the MAC Scale remained little changed despite the division of two scales and the suggested removal of six items. The refined scales correlated with the Hospital Anxiety and Depression scale and the Medical Coping Modes Questionnaire, indicating good concurrent validity.Conclusions. While reasonable reliability of the original scales persists through analyses of the MAC Scale, the original factor structure could not be reproduced. Six refined constructs with strong construct validity were identified within the overall domain of mental adjustment to cancer.


2009 ◽  
Vol 6 (1) ◽  
pp. 123-128 ◽  
Author(s):  
Jiro Imanishi ◽  
Hiroko Kuriyama ◽  
Ichiro Shigemori ◽  
Satoko Watanabe ◽  
Yuka Aihara ◽  
...  

We examined how aromatherapy massage influenced psychologic and immunologic parameters in 12 breast cancer patients in an open semi-comparative trial. We compared the results 1 month before aromatherapy massage as a waiting control period with those during aromatherapy massage treatment and 1 month after the completion of aromatherapy sessions. The patients received a 30 min aromatherapy massage twice a week for 4 weeks (eight times in total). The results showed that anxiety was reduced in one 30 min aromatherapy massage in State-Trait Anxiety Inventory (STAI) test and also reduced in eight sequential aromatherapy massage sessions in the Hospital Anxiety and Depression Scale (HADS) test. Our results further suggested that aromatherapy massage ameliorated the immunologic state. Further investigations are required to confirm the anxiolytic effect of aromatherapy in breast cancer patients.


2020 ◽  
Vol 9 (2) ◽  
pp. 181
Author(s):  
Ni luh Putu Mahayani ◽  
Ni Komang Sukraandini ◽  
Ni Wayan Suniyadewi

AbstractBreast cancer sufferers have a tendency to experience a decrease of self esteem that make  patients shall showing symptoms such as blaming themself for what they experienced. One way to increase self esteem in cancer patients is by increasing family participation through family support. The aim of this study is to determine the relationship between family support and self esteem in breast cancer patients. This study was using cross sectional design. The study was taken place at the Surgical Oncology Polyclinic, found samples of 188 respondents which was selected with a purposive sampling technique.The results showed that the majority of respondents were in the category of moderate self-esteem were 98 respondents (52.1%) and the category of moderate family support were 96 respondents (51.1%). The Rank Spearmen test results shows p value 0,000 (p <ɑ), means there is a relationship between self-esteem and family support in breast cancer patients with r value of 0.566 (positive relationship). It is expected that the family will always support the patient in every process of treatment, whether in the form of physical, psychological or financial support that could increase the patient's self esteem


Open Medicine ◽  
2009 ◽  
Vol 4 (4) ◽  
pp. 450-453
Author(s):  
Aydan Eroğlu ◽  
Yonca Eğin ◽  
Nejat Akar

AbstractTamoxifen is widely used in the treatment of breast cancer and associated with an increased risk of thromboembolism (TE). An elevated homocysteine is one of the risk factors for TE. The aim of the study was to assess the effect of tamoxifen on serum homocysteine levels in breast cancer patients. We performed a case-control study in 20 female subjects to evaluate the relationship between homocysteine levels, and 5,10-methylenetetrahyrofolate reductase (MTHFR) C677T and dihydrofolate reductase (DHFR) 19-bp intron-1 deletion polymorphisms in breast cancer patients and in control subjects. It was observed that homocysteine levels were decreased during tamoxifen therapy, but this finding was not statistically significant. There was also no statistically significant difference in homocysteine levels between the two groups (p> 0.05). MTHFR C677T and DHFR 19-bp deletion polymorphisms were not associated with serum homocysteine value in either group.


2021 ◽  
Vol 4 (IAHSC) ◽  
pp. 61-66
Author(s):  
Sri Handayani ◽  
Ulfah Nuraini Karim ◽  
Puji Astuti Wiratmo

Introduction: Breast cancer is the most common malignant neoplasm that affects women.  One of the treatments for breast cancer is chemotherapy which is carried out according to a particular schedule with a specified length of therapy to increase the patient's recovery rate.  In addition to the physiological effects, chemotherapy also has a psychological impact on the patient.  Fulfillment of psychosocial needs is important to improve the quality of life of patients caused by changes in physical, social, cognitive, spiritual, emotional and role functions.  The purpose of this study was to determine the relationship between the cycle of chemoteraphy with psychosocial problems in breast cancer patients. Method: This study is a quantitative correlational study using 54 breast cancer patients as samples by purposive sampling.  Data collection was carried out during April 2020 to June 2020 in the chemotherapy room at Koja Hospital, North Jakarta. The Depression Anxiety Stress Scale (DASS 21) questionnaire was used to identify psychosocial problems in breast cancer patients.  Statistical analysis of the Spearman rank test was carried out to analyze the relationship between chemotherapy cycles and psychosocial problems. Results: The results showed that there was a relationship between chemotherapy cycles and psychosocial problems (p value 0.001) although it showed a weak relationship between those  two variables (r 0.257).  Psychosocial problems identified included anxiety (53%), depression (9.3%), low self-esteem (16.7%) and stress (20.4%). Conclusion: Nurses need to provide comprehensive nursing care for patients undergoing chemotherapy including identifying problems related to physical complaints and psychosocial needs so that nursing interventions can be given comprehensively to breast cancer patients undergoing chemotherapy.


2021 ◽  
Vol 6 (1) ◽  
Author(s):  
Lucilla Suparmi ◽  
Fransisca Anjar Rina Setyani

Objective: Chemotheraphy is one of theraphy managements for breast cancer patients. Chemotherapy has some side effects like nausea, gag, alpoesia, etc. Those can increase patients’ anxiety. Then, this anxiety will give impact on sleeping quality disoeder. This research aims to identify the anxiety level of breast cancer patients in chemotheraphy ODC room.Methods: This research used crossectional design. There are 32 respondents as research sample choosen by purposive sample technic.Results: The result shows that most repondents (68,75 %) didnot feel anxiety, 15,63% got mild anxiety, 9,38% got moderate and severe anxiety, and no one got panic anxiety. Most respondents (71,87) had good sleeping quality and 28,13% had poor sleeping quality. There is no relationship between level anxiety and sleeping quality of cancer patients with P value = 0,182.Conclusion: There is no relationship between level anxiety and sleeping quality of cancer patients. Nurse should do persoal approach to patients who are still having severe anxiety and poor sleeping qualitiy.


2020 ◽  
Vol 20 (1) ◽  
pp. 1
Author(s):  
Yuliana Yuliana ◽  
Mustikasari Mustikasari ◽  
Feri Fernandes

Breast cancer is the most common cancer in woman. In Europen there are approximately 175,000 cases found regarding breast cancer and more than 165,000 patients died if the cancer is not controlled, whereas in the United States 44,000 patients died of breast cancer. According to the Hospital Statistics in the Breast Cancer Hospital Information System, Indonesia is the first rank of the most breast cancer patients which can be found in almost every hospital in Indonesia. The impact of breast cancer on the aspects of bio- psycho- social- spritual in breast cancer patients include anxiety and depression.Unfortunately this study is not commonly carried aut by researchers. One effort to reduce anxiety and depression in breast cancer patients is to provide social support. This study aims to determine the relationship of social support with anxiety and depression in breast cancer patients. The method used is analytic cross- sectional study.Also this study is conducted at Raden Mattaher Hospital in Jambi, with 97 breast cancer patients were picked as participants. Data sampling that is utilised in this study was incidental sampling.The data were colleted by using several methods, such as the Multidemensional Scale of Perceived of Social Support (MSPSS) instrument, and the Hospital Anxiety and depression Scale (HADS), and later those data were analysed with Bivariate Analysis using the Chi Square test. The results showed that the average age of breast cancer patient is 46,57, length of diagnosis is 28,59 months, low education level patient is 68,0%, patient who has merried is 91,8%, unemployed patient is 78,4%, patient who reseived good social support is 54,6%, patient with anxiety is 49,5%, and patient with depression is 50,5%. There is relationship between social support and anxiety in breast cancer patients, with (p:0,000).


Sign in / Sign up

Export Citation Format

Share Document